MHRA Update including recall alert

MHRA Update including recall alert

January 7, 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of  Irbesartan / Hydrochlorothiazide containing products. Actavis Group PTC EHF is recalling the batches identified below from pharmacies as a precautionary measure due to possible contamination with N-nitrosodiethylamine (NDEA). Community pharmacy teams should stop supplying the above products/batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process. To view the alert please visit the GOV.UK website.

Please note a new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 5 December 2018) was published in December 2018. To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.




More Latest News >

NHSmail: Changes to password policy

NHS Digital is introducing an improved NHSmail password policy, which will include less frequent password changes. NHSmail users’ passwords will...

CPPE: Emergency contraception workshops

The Centre for Pharmacy Postgraduate Education (CPPE) is offering two-hour workshops on pharmacy emergency contraception services over the next few months....

NPA Bursary applications

Pharmacists can now apply for the National Pharmacy Association’s (NPA) £10,000 Health Education Foundation bursary. The annual bursary aims to...